We serve BOC-CYS(4-MEOBZL)-OH CAS:18942-46-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:BOC-CYS(4-MEOBZL)-OH
CAS.NO: 18942-46-6
Molecular Formula: C16H23NO5S
Molecular Weight: 341.42300
Synonyms:
Boc-Cys(p-methoxybenzyl)
BOC-L-CYS(MOB)-OH
Boc-Cys(4-MeBzl)-OH
BOC-CYS(4-MOB)-OH
Boc-S-(4-methoxybenzyl)-L-cysteine
BOC-L-CYS(4MOBZL)-OH
BOC-CYSTEINE(MOB)-OH
BOC-CYS(MBZL)
Boc-Cys(p-MeOBzl)-OH
BOC-CYS(MOB)-OH
BOC-CYS(MEOBZL)-OH
Boc-Cys(pMeOBzl)-OH
Boc-Cys(MBzl)-OH
BOC-Cys(MeOBzl)
Physical and Chemical Properties:
Density: 1.205 g / cm3
Boiling point: 514ºC at 760 mmHg
Flash point: 264.7ºC
Refractive index: 1.546
Specification:
Appearance: White powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like BOC-CYS(4-MEOBZL)-OH chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,BOC-Cys(MeOBzl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BOC-L-CYS(MOB)-OH Use and application,Boc-S-(4-methoxybenzyl)-L-cysteine technical grade,usp/ep/jp grade.
Related News: Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures.2-Bromo-3-Fluoroaniline manufacturer But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said.4'-Chloroacetoacetanilide supplier From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.N6-trifluoroacetyl-L-lysine vendor Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.
